Treating for two : a national strategy for safer medication use in pregnancy

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Treating for two : a national strategy for safer medication use in pregnancy

Published Date:

11/26/14

Language:

English

[PDF-1.20 MB]

Details:

Corporate Authors:

National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention (U.S.)). Division of Birth Defects and Developmental Disabilities.

Description:

Medication use during pregnancy is common and increasing. Almost all pregnant women face decisions about whether or not it is safe to take a medication during pregnancy. Should Elizabeth continue taking her allergy medicine while pregnant? Should Clara take a medication to alleviate her nausea and vomiting? Marie just found out that she’s pregnant; should she switch her antidepressant to a safer one? Women and healthcare providers don’t have enough information to answer these questions. Treating for Two is CDC’s prescription for this problem.

CS252486A

ncbddd_birth-defects_medicationuseonepager_cdcrole.pdf

Subject:

[+]

Document Type:

Pamphlet (or booklet)

Collection(s):

Stephen B. Thacker CDC Library collection

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

Safer medication use in pregnancy

Corporate Authors:

Centers for Disease Control and Prevention (U.S.).

Published Date:

7/9/14

Source:

Treating for two

File Type:

[PDF - 1.28 MB]
Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention—convened meeting

Personal Author:

Broussard, Cheryl S.; Frey, Meghan T.; Hernandez-Diaz, Sonia; Greene, Michael F.; Chambers, Christina D.; Sahin, Leyla; Collins Sharp, Beth A.; Honein, Margaret A.;

Published Date:

May 29 2014

Source:

Am J Obstet Gynecol. 211(3):208-214.e1

Description:

To address information gaps that limit informed clinical decisions on medication use in pregnancy, the Centers for Disease Control and Prevention (CDC) solicited expert input on a draft prototype outlining a systematic approach to evaluating the qual...

File Type:

[PDF - 256.86 KB]
HIV Prevention in Care and Treatment Settings: Baseline Risk Behaviors among HIV Patients in Kenya, Namibia, and Tanzania

Personal Author:

Kidder, Daniel P.; Bachanas, Pam; Medley, Amy; Pals, Sherri; Nuwagaba-Biribonwoha, Harriet; Ackers, Marta; Howard, Andrea; DeLuca, Nick; Mbatia, Redempta; Sheriff, Muhsin; Arthur, Gilly; Katuta, Frieda; Cherutich, Peter; Somi, Geoffrey;

Corporate Authors:

for the PwP Evaluation Study team

Published Date:

Feb 25 2013

Source:

PLoS One. 2013; 8(2).

Series:

PEPFAR

Description:

Trial RegistrationClinicalTrials.gov NCT01256463

File Type:

[PDF - 191.80 KB]
Maximizing the impact of HIV prevention efforts: Interventions for couples

Personal Author:

Medley, Amy; Baggaley, Rachel; Bachanas, Pamela; Cohen, Myron; Shaffer, Nathan; Lo, Ying-Ru;

Published Date:

May 08 2013

Source:

AIDS Care. 25(12):1569-1580

Description:

Despite efforts to increase access to HIV testing and counseling services, population coverage remains low. As a result, many people in sub-Saharan Africa do not know their own HIV status or the status of their sex partner(s). Recent evidence, howeve...

File Type:

[PDF - 217.37 KB]
CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome

Personal Author:

Ko, Jean Y.; Wolicki, Sara; Barfield, Wanda D.; Patrick, Stephen W.; Broussard, Cheryl S.; Yonkers, Kimberly A.; Naimon, Rebecca; Iskander, John;

Published Date:

Mar 10 2017

Source:

MMWR Morb Mortal Wkly Rep. 66(9):242-245.

Description:

Neonatal abstinence syndrome (NAS) is a drug withdrawal syndrome that most commonly occurs in infants after in utero exposure to opioids, although other substances have also been associated with the syndrome (1). NAS usually appears within 48-72 hour...

File Type:

[PDF - 187.23 KB]